FDA Sets New ANDA Performance Goals in Draft Guidance

Drug Industry Daily
The FDA has laid out new goals for speeding up its handling of regulatory submissions from generics makers that eventually call for 90 percent of some prior approval supplements to be acted on within six months and ANDA amendments to be acted on within 10 months.

To View This Article:


Subscribe To Drug Industry Daily